Document is current
Any future updates will be listed below
-
Authors
Guo, Liang-Kun
Su, Yi
Zhang, Yu-Ya-Nan
Yu, Hao
Lu, Zhe
Li, Wen-Qiang
Yang, Yong-Feng
Xiao, Xiao
Yan, Hao
Lu, Tian-Lan
Li, Jun
Liao, Yun-Dan
Kang, Zhe-Wei
Wang, Li-Fang
Li, Yue
Li, Ming
Liu, Bing
Huang, Hai-Liang
Lv, Lu-Xian
Yao, Yin
Tan, Yun-Long
Breen, Gerome
Everall, Ian
Wang, Hong-Xing
Huang, Zhuo
Zhang, Dai
Yue, Wei-Hua
-
Clinical Trials BETA
Clinical trials referenced in this document:
chictr-rnc-09000521 at Chinese Clinical Trial Registrychictr-rnc-09000522 at Chinese Clinical Trial RegistryDocuments that mention this clinical trial
Documents that mention this clinical trial
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81825009, 82071505, 81901358)
Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (2021-I2M-C&T-B-099, 2019-I2M-5-006)
Epilepsy Research Program of the Ontario Brain Institute (2020-NKX-XM-12)
Peking University Clinical Scientist Program (BMU2019LCKXJ012)
National Key R&D Program of China (2021YFF1201103, 2016YFC1307000)
- License Information
-
More Information
Article History
Received: 22 December 2022
Accepted: 5 May 2023
First Online: 2 June 2023
Declarations
:
: All study protocols were approved by the Institutional Ethics Review Boards at each site and can be accessed in the Chinese Clinical Trial Registry ( and ). Written informed consents were obtained from all participants.
: All participants in this study have provided consent for their deidentified data to contribute to publication of the research findings.
: The authors declare that they have no competing interests.
